Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis: A contemporary evaluation

Mary E Westerman, Stephen A Boorjian, Brian J Linder, Mary E Westerman, Stephen A Boorjian, Brian J Linder

Abstract

Introduction: Hemorrhagic cystitis (HC) represents a challenging clinical entity. While various intravesical agents have been utilized in this setting, limited data exist regard¬ing safety or efficacy. Herein, then, we evaluated the effectiveness and complications associated with intravesical alum instillation for HC in a contemporary cohort.

Materials and methods: We identified 40 patients treated with intravesical alum for HC between 1997-2014. All patients had failed previous continuous bladder irrigation with normal saline and clot evacuation. Treatment success was defined as requiring no additional therapy beyond normal saline irrigation after alum instillation.

Results: Median patient age was 76.5 years (IQR 69, 83). Pelvic radiation was the most common etiology for HC (n=38, 95%). Alum use decreased patient's transfusion requirement, with 82% (32/39) receiving a transfusion within 30 days before alum instillation (median 4 units) versus 59% (23/39) within 30 days after completing alum (median 3 units) (p=0.05). In total, 24 patients (60%) required no additional therapy prior to hospital discharge. Moreover, at a median follow-up of 17 months (IQR 5, 38.5), 13 patients (32.5%) remained without additional treatment for HC. Adverse ef¬fects were reported in 15 patients (38%), with bladder spasms representing the most common event (14/40; 35%). No clinical evidence of clinically significant systemic absorption was detected.

Conclusion: Intravesical alum therapy is well-tolerated, with resolution of HC in ap¬proximately 60% of patients, and a durable response in approximately one-third. Given its favorable safety/efficacy profile, intravesical alum may be considered as a first-line treatment option for patients with HC.

Keywords: Cystitis; Hematuria; Urinary Bladder.

Conflict of interest statement

Conflicts of Interest: None declared.

Copyright® by the International Brazilian Journal of Urology.

References

    1. Abt D, Bywater M, Engeler DS, Schmid HP. Therapeutic options for intractable hematuria in advanced bladder cancer. Int J Urol. 2013;20:651–660.
    1. Linder BJ, Boorjian SA. Management of Emergency Bleeding, Recalcitrant Clots, and Hemorrhagic Cystitis. AUA Updat. Ser. 2014
    1. Kouriefs C, Gordon SJ. The management of intractable haematuria. BJU Int. 2001;88:301–302.
    1. Ostroff EB, Chenault OW., Jr. Alum irrigation for the control of massive bladder hemorrhage. J Urol. 1982;128:929–930.
    1. Arrizabalaga M, Extramiana J, Parra JL, Ramos C, Díaz González R, Leiva O. Treatment of massive haematuria with aluminous salts. Br J Urol. 1987;60:223–226.
    1. Praveen BV, Sankaranarayanan A, Vaidyanathan S. A comparative study of intravesical instillation of 15(s) 15 Me alpha and alum in the management of persistent hematuria of vesical origin. Int J Clin Pharmacol Ther Toxicol. 1992;30:7–7.
    1. Goel AK, Rao MS, Bhagwat AG, Vaidyanathan S, Goswami AK, Sen TK. Intravesical irrigation with alum for the control of massive bladder hemorrhage. J Urol. 1985;133:956–957.
    1. Kennedy C, Snell ME, Witherow RO. Use of alum to control intractable vesical haemorrhage. Br J Urol. 1984;56:673–675.
    1. Nurmi M, Puntala P, Torniainen K. Alum irrigation in the treatment of severe haemorrhage from the bladder. Ann Chir Gynaecol. 1987;76:173–175.
    1. Takashi M, Kondo A, Kato K, Murase T, Miyake K. Evaluation of intravesical alum irrigation for massive bladder hemorrhage. Urol Int. 1988;43:286–288.
    1. Goswami AK, Mahajan RK, Nath R, Sharma SK. How safe is 1% alum irrigation in controlling intractable vesical hemorrhage? J Urol. 1993;149:264–267.
    1. Rastinehad AR, Kavoussi LR, Noble MJ. AUA Update Series. 2010:26–26.
    1. Kavoussi LR, Gelstein LD, Andriole GL. Encephalopathy and an elevated sérum aluminum level in a patient receiving intravesical alum irrigation for severe urinary hemorrhage. J Urol. 1986;136:665–667.
    1. Linder BJ, Tarrell RF, Boorjian SA. Cystectomy for refractory hemorrhagic cystitis: contemporary etiology, presentation and outcomes. J Urol. 2014;192:1687–1692.

Source: PubMed

3
Iratkozz fel